What's breaking now, across thousands of outlets.
Hims & Hers Health shares are down after the telehealth firm reduced the top end of its adjusted Ebitda forecast for the full year. Madison Muller reports on "Bloomberg The Close." (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
…A spotlight on integrated specialist care, diagnostics, and wellness services available to individuals, families and organisations in Lagos, Nigeria As read more OneHealth by AXA expands access to…
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as…
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the stem cells that drive high-risk myelodysplastic syndromes (MDS), a…
Image-based spatial transcriptomics was applied to longitudinal human endomyocardial biopsy samples from 62 adult and pediatric heart transplant recipients during and after histologically diagnosed…
(MedPage Today) -- Outcomes have substantially improved over time in patients with relapsed or refractory classical Hodgkin lymphoma who underwent hematopoietic cell transplantation (HCT), according…
For most healthy people, Cryptococcus is an unnoticed infection. The immune system walls it off in the lungs and keeps it dormant for life.
